Thomas Myers - Jun 18, 2021 Form 4 Insider Report for PURE BIOSCIENCE, INC. (PURE)

Role
Chief Operating Officer
Signature
/s/ Thomas Myers
Stock symbol
PURE
Transactions as of
Jun 18, 2021
Transactions value $
$0
Form type
4
Date filed
6/22/2021, 08:25 PM
Next filing
Oct 4, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PURE Stock Option (Right to Buy) Award $0 +100K $0.00 100K Jun 18, 2021 Common Stock 100K $0.45 Direct F1
transaction PURE Stock Option (Right to Buy) Award $0 +125K $0.00 125K Jun 18, 2021 Common Stock 125K $0.45 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option shares shall vest and become exercisable as follows: (i) 50% of the option will vest on the earlier of the date of the Issuer's annual meeting of stockholders held in 2022 or January 15, 2022 and (ii) 50% of the options will vest on the earlier of the date of the Issuer's annual meeting of stockholders held in 2023 or January 15, 2023.
F2 The option shares shall vest and become exercisable in four equal installments on September 18, 2021, December 18, 2021, March 18, 2022 and June 18, 2022.